ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

ClinicalTrials.gov ID: NCT00033592

Public ClinicalTrials.gov record NCT00033592. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 3:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Trial Comparing Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion For Smoking Cessation Efficacy And Relapse Prevention

Study identification

NCT ID
NCT00033592
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
1,708 participants

Conditions and interventions

Conditions

Interventions

  • bupropion hydrochloride Drug
  • nicotine Drug
  • placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Jun 30, 2006
Completion
Jun 30, 2006
Last update posted
Jul 12, 2016

2002 – 2006

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
MBCCOP-Howard University Cancer Center Washington D.C. District of Columbia 20060
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
Cancer Center of Kansas - Wichita Wichita Kansas 67214
CCOP - Ochsner New Orleans Louisiana 70121
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CentraCare Clinic Saint Cloud Minnesota 56303
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Medcenter One Health System Bismarck North Dakota 58501
CCOP - Merit Care Hospital Fargo North Dakota 58122
Altru Health Systems Grand Forks North Dakota 58201
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456
CCOP - Sooner State Tulsa Oklahoma 74136
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
Rapid City Regional Hospital Rapid City South Dakota 57709
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00033592, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2016 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00033592 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →